Juming Yan

2.0k total citations
27 papers, 880 citations indexed

About

Juming Yan is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Juming Yan has authored 27 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Oncology. Recurrent topics in Juming Yan's work include Cancer, Stress, Anesthesia, and Immune Response (3 papers), Immunotherapy and Immune Responses (3 papers) and Immune Cell Function and Interaction (3 papers). Juming Yan is often cited by papers focused on Cancer, Stress, Anesthesia, and Immune Response (3 papers), Immunotherapy and Immune Responses (3 papers) and Immune Cell Function and Interaction (3 papers). Juming Yan collaborates with scholars based in China, Australia and United States. Juming Yan's co-authors include Mark J. Smyth, Michele W.L. Teng, Stacey Allen, Hongyu Zhou, Jing Liu, Hongbin Zhang, Jason Madore, Yan Li, Guiguang Cheng and Yaping Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Juming Yan

25 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juming Yan China	17	316	295	282	98	93	27	880
Tae‐Hwe Heo South Korea	18	429 1.4×	248 0.8×	191 0.7×	51 0.5×	58 0.6×	64	1.0k
Sakshi Sikka Singapore	7	531 1.7×	125 0.4×	368 1.3×	76 0.8×	98 1.1×	8	904
Li Nan United States	19	566 1.8×	166 0.6×	375 1.3×	59 0.6×	47 0.5×	44	1.1k
Jinmei Jin China	17	584 1.8×	121 0.4×	232 0.8×	76 0.8×	104 1.1×	38	988
Yunxue Zhao China	18	493 1.6×	245 0.8×	152 0.5×	137 1.4×	29 0.3×	39	890
Minsoo Koh South Korea	13	391 1.2×	128 0.4×	178 0.6×	48 0.5×	37 0.4×	17	717
Mei Zhang China	17	334 1.1×	140 0.5×	133 0.5×	39 0.4×	120 1.3×	54	842
Hongfei Tong China	18	392 1.2×	96 0.3×	133 0.5×	71 0.7×	86 0.9×	36	867
Sook‐Kyoung Heo South Korea	16	235 0.7×	183 0.6×	106 0.4×	56 0.6×	44 0.5×	36	648
Feifeng Song China	15	320 1.0×	107 0.4×	187 0.7×	36 0.4×	47 0.5×	53	717

Countries citing papers authored by Juming Yan

Since Specialization

Citations

This map shows the geographic impact of Juming Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juming Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juming Yan more than expected).

Fields of papers citing papers by Juming Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juming Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juming Yan. The network helps show where Juming Yan may publish in the future.

Co-authorship network of co-authors of Juming Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Juming Yan. A scholar is included among the top collaborators of Juming Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juming Yan. Juming Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pan, Qi, Lei Li, Juming Yan, et al.. (2025). Tissue inhibitor of metalloproteinase 1 promotes ferroptosis and suppresses prostate cancer metastasis. Journal of Biological Chemistry. 301(5). 108473–108473.

Putz, Eva Maria, Yaqi Liu, Zhuo Fu, et al.. (2025). Metabotropic glutamate receptor 4-mediated glutamatergic signaling reshapes the tumor microenvironment by regulating dendritic cell maturation. Nature Communications. 16(1). 5874–5874. 1 indexed citations

Qian, Cheng, Teng Zhang, Guanglu Dong, et al.. (2024). Targeting PKM2 signaling cascade with salvianic acid A normalizes tumor blood vessels to facilitate chemotherapeutic drug delivery. Acta Pharmaceutica Sinica B. 14(5). 2077–2096. 16 indexed citations

Hu, Jing, Eva Maria Putz, Simin Zheng, et al.. (2023). NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophages. Proceedings of the National Academy of Sciences. 120(47). e2302126120–e2302126120. 17 indexed citations

Hu, Jing, et al.. (2023). The role of glutamate receptors in the regulation of the tumor microenvironment. Frontiers in Immunology. 14. 1123841–1123841. 41 indexed citations

Yan, Juming, Xian-Yang Li, Amelia Roman Aguilera, et al.. (2020). Control of Metastases via Myeloid CD39 and NK Cell Effector Function. Cancer Immunology Research. 8(3). 356–367. 63 indexed citations

Kansara, Maya, Puiyi Pang, Aurélie Dutour, et al.. (2019). Infiltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23. Cancer Discovery. 9(11). 1511–1519. 35 indexed citations

Yan, Juming, Stacey Allen, Elizabeth S. McDonald, et al.. (2019). MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1. Cancer Discovery. 10(1). 124–141. 106 indexed citations

Zhou, Hongyu, Chunlei Yu, Lingmei Kong, et al.. (2019). B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells. Oncogene. 38(18). 3371–3386. 30 indexed citations

10.

Yan, Juming, Stacey Allen, Dipti Vijayan, et al.. (2018). Experimental Lung Metastases in Mice Are More Effectively Inhibited by Blockade of IL23R than IL23. Cancer Immunology Research. 6(8). 978–987. 13 indexed citations

11.

Harjunpää, Heidi, Stephen J. Blake, Elizabeth Ahern, et al.. (2018). Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis. OncoImmunology. 7(7). e1445949–e1445949. 37 indexed citations

12.

Yan, Juming, Mark J. Smyth, & Michele W.L. Teng. (2017). Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer. Cold Spring Harbor Perspectives in Biology. 10(7). a028530–a028530. 108 indexed citations

13.

Yan, Juming, Hongyu Zhou, Lingmei Kong, et al.. (2013). Identification of two novel inhibitors of mTOR signaling pathway based on high content screening. Cancer Chemotherapy and Pharmacology. 72(4). 799–808. 8 indexed citations

14.

Wang, Fang, Juming Yan, Yanfen Niu, et al.. (2013). Mangiferin and its aglycone, norathyriol, improve glucose metabolism by activation of AMP-activated protein kinase. Pharmaceutical Biology. 52(1). 68–73. 35 indexed citations

15.

Luo, Rong‐Hua, Juming Yan, Yan Li, et al.. (2013). Structure and bioactivity of triterpenoids from the stems of Schisandra sphenanthera. Archives of Pharmacal Research. 37(2). 168–174. 27 indexed citations

16.

Liu, Lanxiang, Xuequan Wang, Juming Yan, et al.. (2013). Synthesis and antitumor activities of novel dibenzo[b,d]furan–imidazole hybrid compounds. European Journal of Medicinal Chemistry. 66. 423–437. 45 indexed citations

17.

Su, Jia, Pei‐Ji Zhao, Lingmei Kong, et al.. (2013). Trichothecin Induces Cell Death in NF-κB Constitutively Activated Human Cancer Cells via Inhibition of IKKβ Phosphorylation. PLoS ONE. 8(8). e71333–e71333. 18 indexed citations

18.

Zhang, Bing‐Jie, Juming Yan, Yaping Liu, et al.. (2013). Alkaloids from Ochrosia borbonica. Helvetica Chimica Acta. 96(12). 2288–2298. 14 indexed citations

19.

Lai, Yongji, Yongbo Xue, Mengke Zhang, et al.. (2013). Scapiformolactones A–I: Germacrane sesquiterpenoids with an unusual Δ3-15,6-lactone moiety from Salvia scapiformis. Phytochemistry. 96. 378–388. 15 indexed citations

20.

Shang, Shan‐Zhai, Juming Yan, Haibo Zhang, et al.. (2012). Two new neolignans from Manglietia insignis. Natural Products and Bioprospecting. 2(5). 227–230. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact